Julie K Schwarz
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julie K Schwarz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05521997 · Glutaminase Inhibition and Chemoradiation in Advanced Cervical CancerWashington University School of Medicine · not yet recruiting · Advanced Cervical Carcinoma, Cervical Cancer, Cervix Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Research Project Cervical CancerU54CA274318 · NCI · WASHINGTON UNIVERSITY · fiscal years 2023 to 2026 · $214,290 awarded in 2026Same name and institution; not confirmed by an ID
- Mechanistic Basis of Cardiac Irradiation as a Therapy for Ventricular TachycardiaR01HL163274 · NHLBI · WASHINGTON UNIVERSITY · fiscal years 2022 to 2025 · $787,084 awarded in 2025Same name and institution; not confirmed by an ID
- Optimizing radiation therapy through the manipulation of glutamine metabolismR01CA181745 · NCI · WASHINGTON UNIVERSITY · fiscal years 2014 to 2025 · $748,125 awarded in 2025Grant number is on one of their registry trials
- Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor ImmunityR01CA248917 · NCI · WASHINGTON UNIVERSITY · fiscal years 2020 to 2024 · $412,324 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:50 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis.Nat Commun · 2021142 citationsRCR 10.0
- Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck.Invest New Drugs · 200874 citationsRCR 1.5
- 56 citationsRCR 2.0
- 56 citationsRCR 2.5
- Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.Int J Radiat Oncol Biol Phys · 202239 citationsRCR 3.3
- Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003.J Clin Oncol · 202035 citationsRCR 1.3
- Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma.Radiother Oncol · 201927 citationsRCR 1.1
- Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer.Clin Exp Metastasis · 201519 citationsRCR 0.6
- Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.Am J Clin Oncol · 201918 citationsRCR 0.8
- Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients.Int J Radiat Oncol Biol Phys · 201110 citationsRCR 0.4